Just When You Thought It Was Over: Eleventh Circuit Deepens Disagreement on FCA's Tolling Provision
Client Alert | 1 min read | 06.13.18
In U.S. ex rel. Hunt v. Cochise Consultancy Inc., the Eleventh Circuit held that a relator in a non-intervened qui tam action may rely on the FCA’s tolling provision in 31 U.SC. § 3731(b)(2), which expands the 6-year statute of limitations to allow suits to be brought within 3 years of the date that the relevant government official learns of the alleged violation. In so holding, the court disagreed with already divergent views from the Fourth, Tenth, and Ninth Circuits, increasing the depth of the circuit split on this issue. C&M attorneys discuss the Eleventh Circuit’s decision and its potential impact in a recent post for Crowell & Moring’s Government Contracts Legal Forum.
Contacts
Insights
Client Alert | 6 min read | 04.29.26
CMS Seeks to Expand Interoperability Requirements to Drug Pre-Authorization (FAQ)
On April 10, 2026, the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule (2026 CMS Interoperability Standards and Prior Authorization for Drugs, or CMS-0062-P) outlining the agency’s plans to impose new interoperability requirements on payors participating in certain Medicare and Medicaid programs. As described by the agency in a recent press release, the proposed rule “builds on” prior rulemaking by clarifying and enhancing interoperability requirements for payors’ prior authorization processes, specifically those associated with coverage requests for pharmaceutical therapies.
Client Alert | 8 min read | 04.27.26
Client Alert | 5 min read | 04.27.26
Drift Protocol Exploit: Why “Social Trust” Is the Newest Cybersecurity Gap
Client Alert | 4 min read | 04.27.26
Gaming Addiction Litigation: Turner v. Epic Games & Roblox and What It Means for the Industry
